| 0 |
ELSBERG SYNDROME |
5 |
0.3846 |
| 1 |
HAEMORRHAGIC ADRENAL INFARCTION |
6 |
0.3750 |
| 2 |
WRONG DEVICE USED |
77 |
0.1174 |
| 3 |
FALLOPIAN TUBE NEOPLASM |
2 |
0.0952 |
| 4 |
CORRECTED TRANSPOSITION OF GREAT VESSELS |
2 |
0.0909 |
| 5 |
AUTONOMIC DYSREFLEXIA |
13 |
0.0802 |
| 6 |
CLINICALLY ISOLATED SYNDROME |
4 |
0.0421 |
| 7 |
DRUG ADMINISTERED IN WRONG DEVICE |
40 |
0.0409 |
| 8 |
PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS |
5 |
0.0403 |
| 9 |
TOXIC NEUROPATHY |
13 |
0.0330 |
| 10 |
RELAPSING-REMITTING MULTIPLE SCLEROSIS |
28 |
0.0324 |
| 11 |
BORDERLINE OVARIAN TUMOUR |
2 |
0.0299 |
| 12 |
RELAPSING MULTIPLE SCLEROSIS |
9 |
0.0298 |
| 13 |
AMNIORRHEXIS |
2 |
0.0278 |
| 14 |
OVARIAN GRANULOSA CELL TUMOUR |
2 |
0.0267 |
| 15 |
MUCOCUTANEOUS LEISHMANIASIS |
3 |
0.0246 |
| 16 |
PREMATURE BABY DEATH |
2 |
0.0244 |
| 17 |
EMBOLIA CUTIS MEDICAMENTOSA |
19 |
0.0239 |
| 18 |
PATERNAL EXPOSURE BEFORE PREGNANCY |
7 |
0.0230 |
| 19 |
ADMINISTRATION SITE INDURATION |
2 |
0.0222 |
| 20 |
MENINGITIS STAPHYLOCOCCAL |
3 |
0.0211 |
| 21 |
EXPANDED DISABILITY STATUS SCALE SCORE INCREASED |
24 |
0.0192 |
| 22 |
LACK OF INJECTION SITE ROTATION |
28 |
0.0160 |
| 23 |
HERPES SIMPLEX REACTIVATION |
6 |
0.0157 |
| 24 |
CSF OLIGOCLONAL BAND PRESENT |
2 |
0.0154 |
| 25 |
HERPES ZOSTER REACTIVATION |
4 |
0.0153 |
| 26 |
ADMINISTRATION SITE IRRITATION |
2 |
0.0143 |
| 27 |
INJECTED LIMB MOBILITY DECREASED |
2 |
0.0140 |
| 28 |
TACHYCARDIA PAROXYSMAL |
4 |
0.0138 |
| 29 |
INJECTION SITE NECROSIS |
27 |
0.0132 |
| 30 |
MULTIPLE SCLEROSIS |
599 |
0.0125 |
| 31 |
HIGH RISK PREGNANCY |
5 |
0.0123 |
| 32 |
MULTIPLE SCLEROSIS PSEUDO RELAPSE |
4 |
0.0118 |
| 33 |
ENCEPHALITIS BRAIN STEM |
2 |
0.0116 |
| 34 |
OVARIAN FAILURE |
6 |
0.0112 |
| 35 |
BRAIN SCAN ABNORMAL |
6 |
0.0108 |
| 36 |
LIPOATROPHY |
10 |
0.0105 |
| 37 |
SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS |
19 |
0.0101 |
| 38 |
IMMEDIATE POST-INJECTION REACTION |
11 |
0.0100 |
| 39 |
INJECTION SITE MASS |
351 |
0.0095 |
| 40 |
URTICARIAL VASCULITIS |
5 |
0.0095 |
| 41 |
JC VIRUS INFECTION |
15 |
0.0094 |
| 42 |
INJECTION SITE INDENTATION |
20 |
0.0092 |
| 43 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
11 |
0.0092 |
| 44 |
PULMONARY NECROSIS |
3 |
0.0088 |
| 45 |
PREMATURE MENOPAUSE |
8 |
0.0087 |
| 46 |
CAUDA EQUINA SYNDROME |
6 |
0.0078 |
| 47 |
MULTIPLE SCLEROSIS RELAPSE |
518 |
0.0076 |
| 48 |
ENCEPHALOMYELITIS |
2 |
0.0073 |
| 49 |
INJECTION SITE ATROPHY |
12 |
0.0073 |
| 50 |
ENTEROCOLITIS BACTERIAL |
2 |
0.0072 |
| 51 |
MUSCLE STRENGTH ABNORMAL |
3 |
0.0072 |
| 52 |
ANAL SPHINCTER ATONY |
3 |
0.0070 |
| 53 |
LACK OF ADMINISTRATION SITE ROTATION |
2 |
0.0066 |
| 54 |
TUNNEL VISION |
12 |
0.0064 |
| 55 |
OESOPHAGEAL ATRESIA |
4 |
0.0064 |
| 56 |
NECROTISING RETINITIS |
4 |
0.0063 |
| 57 |
PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS |
3 |
0.0062 |
| 58 |
INJECTION RELATED REACTION |
10 |
0.0061 |
| 59 |
NEUROMYELITIS OPTICA |
2 |
0.0060 |
| 60 |
ADMINISTRATION SITE BRUISE |
2 |
0.0058 |
| 61 |
INJECTION SITE INDURATION |
71 |
0.0055 |
| 62 |
INJECTION SITE SCAR |
15 |
0.0053 |
| 63 |
INJECTION SITE URTICARIA |
129 |
0.0053 |
| 64 |
INJECTION SITE PUSTULE |
2 |
0.0052 |
| 65 |
INJECTION SITE PARAESTHESIA |
8 |
0.0052 |
| 66 |
FAT TISSUE DECREASED |
2 |
0.0051 |
| 67 |
JC POLYOMAVIRUS TEST POSITIVE |
6 |
0.0051 |
| 68 |
PRODUCT SUBSTITUTION |
2 |
0.0050 |
| 69 |
BLADDER DYSFUNCTION |
5 |
0.0049 |
| 70 |
DEVELOPMENTAL HIP DYSPLASIA |
4 |
0.0048 |
| 71 |
PULMONARY VALVE STENOSIS CONGENITAL |
2 |
0.0046 |
| 72 |
PROGRESSIVE MULTIPLE SCLEROSIS |
5 |
0.0043 |
| 73 |
INJECTION SITE CELLULITIS |
8 |
0.0043 |
| 74 |
PROTHROMBIN LEVEL DECREASED |
4 |
0.0043 |
| 75 |
WEST NILE VIRAL INFECTION |
3 |
0.0040 |
| 76 |
MYELITIS |
6 |
0.0039 |
| 77 |
INJURY CORNEAL |
2 |
0.0038 |
| 78 |
INJECTION SITE SWELLING |
292 |
0.0038 |
| 79 |
LIPODYSTROPHY ACQUIRED |
8 |
0.0038 |
| 80 |
MOLLUSCUM CONTAGIOSUM |
2 |
0.0037 |
| 81 |
INJECTION SITE PRURITUS |
246 |
0.0037 |
| 82 |
INJECTION SITE WARMTH |
74 |
0.0036 |
| 83 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
6 |
0.0034 |
| 84 |
RETINAL VASCULAR DISORDER |
2 |
0.0034 |
| 85 |
PARAPARESIS |
6 |
0.0034 |
| 86 |
INJECTION SITE DISCOLOURATION |
42 |
0.0034 |
| 87 |
INFECTIOUS PLEURAL EFFUSION |
5 |
0.0033 |
| 88 |
INJECTION SITE INFLAMMATION |
16 |
0.0032 |
| 89 |
BAND SENSATION |
4 |
0.0032 |
| 90 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
26 |
0.0031 |
| 91 |
INJECTION SITE ERYTHEMA |
391 |
0.0031 |
| 92 |
CEREBELLAR ATAXIA |
3 |
0.0031 |
| 93 |
RENAL SURGERY |
2 |
0.0031 |
| 94 |
IDIOSYNCRATIC DRUG REACTION |
3 |
0.0031 |
| 95 |
INJECTION SITE EXTRAVASATION |
37 |
0.0030 |
| 96 |
ACUTE PROMYELOCYTIC LEUKAEMIA |
3 |
0.0029 |
| 97 |
OPTIC NEURITIS |
26 |
0.0029 |
| 98 |
FACIAL DISCOMFORT |
2 |
0.0028 |
| 99 |
ESCHAR |
2 |
0.0027 |
| 100 |
BRAIN STEM SYNDROME |
2 |
0.0027 |
| 101 |
INJECTION SITE IRRITATION |
33 |
0.0026 |
| 102 |
CROUP INFECTIOUS |
2 |
0.0025 |
| 103 |
OPHTHALMOPLEGIA |
4 |
0.0025 |
| 104 |
SKIN BACTERIAL INFECTION |
2 |
0.0025 |
| 105 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
10 |
0.0025 |
| 106 |
INJECTION SITE REACTION |
167 |
0.0024 |
| 107 |
HYPERTONIC BLADDER |
7 |
0.0024 |
| 108 |
EXPIRED DEVICE USED |
8 |
0.0024 |
| 109 |
QUADRIPARESIS |
4 |
0.0024 |
| 110 |
WALKING DISABILITY |
5 |
0.0024 |
| 111 |
INJECTION SITE DISCOMFORT |
25 |
0.0024 |
| 112 |
FRACTURED COCCYX |
3 |
0.0024 |
| 113 |
INJECTION SITE COLDNESS |
2 |
0.0024 |
| 114 |
INJECTION SITE PAIN |
719 |
0.0023 |
| 115 |
INJECTION SITE OEDEMA |
4 |
0.0023 |
| 116 |
INJECTION SITE VESICLES |
14 |
0.0023 |
| 117 |
INJECTION SITE BRUISING |
183 |
0.0023 |
| 118 |
PERONEAL NERVE PALSY |
13 |
0.0023 |
| 119 |
DEVICE USE ISSUE |
40 |
0.0023 |
| 120 |
AREFLEXIA |
6 |
0.0022 |
| 121 |
MUSCLE NECROSIS |
2 |
0.0022 |
| 122 |
DEVICE MECHANICAL ISSUE |
30 |
0.0022 |
| 123 |
NASAL CAVITY CANCER |
2 |
0.0022 |
| 124 |
BONE CONTUSION |
2 |
0.0022 |
| 125 |
PRODUCT LEAKAGE |
12 |
0.0021 |
| 126 |
INJECTION SITE ULCER |
2 |
0.0021 |
| 127 |
PRODUCT AFTER TASTE |
2 |
0.0021 |
| 128 |
INJECTION SITE HYPOAESTHESIA |
3 |
0.0021 |
| 129 |
INJECTION SITE NODULE |
23 |
0.0021 |
| 130 |
NEEDLE ISSUE |
59 |
0.0020 |
| 131 |
TRIGEMINAL NEURALGIA |
8 |
0.0020 |
| 132 |
MYELOFIBROSIS |
6 |
0.0020 |
| 133 |
CENTRAL NERVOUS SYSTEM LESION |
27 |
0.0020 |
| 134 |
GENITAL HERPES |
3 |
0.0020 |
| 135 |
CORONAVIRUS TEST POSITIVE |
2 |
0.0019 |
| 136 |
INJECTION SITE HYPERSENSITIVITY |
6 |
0.0019 |
| 137 |
CONSCIOUSNESS FLUCTUATING |
2 |
0.0019 |
| 138 |
BURNS THIRD DEGREE |
2 |
0.0019 |
| 139 |
NEUROGENIC BLADDER |
4 |
0.0019 |
| 140 |
OPTIC ATROPHY |
3 |
0.0018 |
| 141 |
FEAR OF INJECTION |
13 |
0.0018 |
| 142 |
ILLUSION |
3 |
0.0018 |
| 143 |
VACCINATION FAILURE |
3 |
0.0018 |
| 144 |
CORNEAL OEDEMA |
4 |
0.0018 |
| 145 |
LYMPHOCYTE COUNT ABNORMAL |
2 |
0.0018 |
| 146 |
SEIZURE LIKE PHENOMENA |
3 |
0.0018 |
| 147 |
MOANING |
2 |
0.0018 |
| 148 |
GLIOBLASTOMA |
3 |
0.0018 |
| 149 |
IMMUNE THROMBOCYTOPENIA |
8 |
0.0017 |
| 150 |
SKIN NECROSIS |
9 |
0.0017 |
| 151 |
PARAPLEGIA |
5 |
0.0017 |
| 152 |
HAEMANGIOMA |
4 |
0.0017 |
| 153 |
SENSE OF OPPRESSION |
2 |
0.0017 |
| 154 |
CORONAVIRUS INFECTION |
11 |
0.0017 |
| 155 |
PULSE ABNORMAL |
4 |
0.0017 |
| 156 |
MONOPARESIS |
3 |
0.0017 |
| 157 |
FEBRILE CONVULSION |
2 |
0.0016 |
| 158 |
PRODUCT SUBSTITUTION ISSUE |
94 |
0.0016 |
| 159 |
POST-ACUTE COVID-19 SYNDROME |
2 |
0.0016 |
| 160 |
HEPATIC NECROSIS |
6 |
0.0016 |
| 161 |
GESTATIONAL HYPERTENSION |
2 |
0.0015 |
| 162 |
PHARYNGEAL SWELLING |
15 |
0.0015 |
| 163 |
INJECTION SITE INFECTION |
5 |
0.0015 |
| 164 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
2 |
0.0015 |
| 165 |
NEAR DEATH EXPERIENCE |
5 |
0.0015 |
| 166 |
CYSTITIS NONINFECTIVE |
2 |
0.0015 |
| 167 |
INJECTION SITE DISCHARGE |
8 |
0.0015 |
| 168 |
LYMPHOPENIA |
21 |
0.0015 |
| 169 |
INJECTION SITE HAEMORRHAGE |
118 |
0.0015 |
| 170 |
MENINGITIS VIRAL |
2 |
0.0015 |
| 171 |
HEAD TITUBATION |
2 |
0.0015 |
| 172 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
2 |
0.0015 |
| 173 |
IMPAIRED SELF-CARE |
3 |
0.0014 |
| 174 |
VARICELLA ZOSTER VIRUS INFECTION |
3 |
0.0014 |
| 175 |
FLUSHING |
147 |
0.0014 |
| 176 |
ANAL INCONTINENCE |
13 |
0.0014 |
| 177 |
SERUM SICKNESS |
4 |
0.0014 |
| 178 |
SLEEP DEFICIT |
3 |
0.0014 |
| 179 |
LIMB MASS |
3 |
0.0014 |
| 180 |
HEMIPARESIS |
23 |
0.0014 |
| 181 |
APRAXIA |
2 |
0.0013 |
| 182 |
PRODUCT DOSE OMISSION |
88 |
0.0013 |
| 183 |
URINARY TRACT DISORDER |
6 |
0.0013 |
| 184 |
PREMATURE SEPARATION OF PLACENTA |
2 |
0.0013 |
| 185 |
BACTERIAL VAGINOSIS |
2 |
0.0013 |
| 186 |
HEPATITIS E |
2 |
0.0013 |
| 187 |
IDIOPATHIC THROMBOCYTOPENIC PURPURA |
2 |
0.0013 |
| 188 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
3 |
0.0013 |
| 189 |
HISTOPLASMOSIS DISSEMINATED |
2 |
0.0013 |
| 190 |
CEREBRAL ATROPHY |
5 |
0.0013 |
| 191 |
OPTIC NERVE DISORDER |
2 |
0.0012 |
| 192 |
IMMUNOSUPPRESSION |
11 |
0.0012 |
| 193 |
GUILLAIN-BARRE SYNDROME |
6 |
0.0012 |
| 194 |
PANNICULITIS |
3 |
0.0012 |
| 195 |
LIQUID PRODUCT PHYSICAL ISSUE |
9 |
0.0012 |
| 196 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
21 |
0.0012 |
| 197 |
ACUTE PSYCHOSIS |
3 |
0.0012 |
| 198 |
PAPILLOMA VIRAL INFECTION |
2 |
0.0012 |
| 199 |
BLOOD IMMUNOGLOBULIN G DECREASED |
3 |
0.0012 |
| 200 |
INJECTION SITE RASH |
37 |
0.0012 |
| 201 |
INJECTION SITE ABSCESS |
3 |
0.0012 |
| 202 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
6 |
0.0012 |
| 203 |
OLIGOHYDRAMNIOS |
4 |
0.0012 |
| 204 |
FEELING HOT |
73 |
0.0012 |
| 205 |
HYPOAESTHESIA |
175 |
0.0012 |
| 206 |
MENOPAUSE |
3 |
0.0012 |
| 207 |
ACUTE SINUSITIS |
2 |
0.0012 |
| 208 |
HEPATIC LESION |
5 |
0.0012 |
| 209 |
DIPLOPIA |
29 |
0.0011 |
| 210 |
NORMAL NEWBORN |
6 |
0.0011 |
| 211 |
SINUS NODE DYSFUNCTION |
2 |
0.0011 |
| 212 |
OPPORTUNISTIC INFECTION |
2 |
0.0011 |
| 213 |
ARTHRITIS INFECTIVE |
5 |
0.0011 |
| 214 |
HEPATITIS ACUTE |
7 |
0.0011 |
| 215 |
ADENOCARCINOMA OF COLON |
2 |
0.0011 |
| 216 |
DYSGRAPHIA |
7 |
0.0011 |
| 217 |
ABORTION INDUCED |
10 |
0.0011 |
| 218 |
NARCOLEPSY |
2 |
0.0011 |
| 219 |
DEVICE ISSUE |
95 |
0.0011 |
| 220 |
CHILLS |
124 |
0.0011 |
| 221 |
MATERNAL EXPOSURE DURING PREGNANCY |
94 |
0.0011 |
| 222 |
PARALYSIS |
15 |
0.0010 |
| 223 |
ANAPHYLACTIC SHOCK |
27 |
0.0010 |
| 224 |
VITAMIN B12 DECREASED |
3 |
0.0010 |
| 225 |
VOMITING PROJECTILE |
3 |
0.0010 |
| 226 |
LYMPHOPROLIFERATIVE DISORDER |
3 |
0.0010 |
| 227 |
DIPLEGIA |
2 |
0.0010 |
| 228 |
EXPOSURE VIA BREAST MILK |
4 |
0.0010 |
| 229 |
CHEST DISCOMFORT |
102 |
0.0010 |
| 230 |
INTRACRANIAL ANEURYSM |
4 |
0.0010 |
| 231 |
FOAMING AT MOUTH |
2 |
0.0010 |
| 232 |
EAR HAEMORRHAGE |
2 |
0.0010 |
| 233 |
EYE INJURY |
3 |
0.0010 |
| 234 |
MUSCLE CONTRACTURE |
2 |
0.0010 |
| 235 |
GOITRE |
4 |
0.0010 |
| 236 |
MUSCLE SPASTICITY |
12 |
0.0010 |
| 237 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
5 |
0.0010 |
| 238 |
SYRINGE ISSUE |
17 |
0.0010 |
| 239 |
OLIGURIA |
6 |
0.0010 |
| 240 |
FEELING COLD |
26 |
0.0009 |
| 241 |
IMMOBILE |
4 |
0.0009 |
| 242 |
INFECTION SUSCEPTIBILITY INCREASED |
2 |
0.0009 |
| 243 |
ENDOMETRIAL CANCER |
2 |
0.0009 |
| 244 |
OTITIS MEDIA |
3 |
0.0009 |
| 245 |
LIMB DISCOMFORT |
28 |
0.0009 |
| 246 |
CONCUSSION |
7 |
0.0009 |
| 247 |
PRODUCT LOT NUMBER ISSUE |
2 |
0.0009 |
| 248 |
ANXIETY DISORDER |
3 |
0.0009 |
| 249 |
INFECTIOUS MONONUCLEOSIS |
2 |
0.0009 |
| 250 |
THROAT TIGHTNESS |
24 |
0.0009 |
| 251 |
BLOOD PRESSURE SYSTOLIC DECREASED |
4 |
0.0009 |
| 252 |
SCAR |
15 |
0.0009 |
| 253 |
ABORTION SPONTANEOUS |
35 |
0.0009 |
| 254 |
SENSORY LOSS |
7 |
0.0009 |
| 255 |
HYPOPNOEA |
3 |
0.0009 |
| 256 |
HYPOAESTHESIA ORAL |
13 |
0.0009 |
| 257 |
EAR PRURITUS |
3 |
0.0009 |
| 258 |
MUSCLE CONTRACTIONS INVOLUNTARY |
3 |
0.0009 |
| 259 |
SKIN REACTION |
12 |
0.0009 |
| 260 |
DECREASED INTEREST |
5 |
0.0008 |
| 261 |
HEAD DISCOMFORT |
15 |
0.0008 |
| 262 |
HAEMORRHAGE SUBCUTANEOUS |
3 |
0.0008 |
| 263 |
PRODUCT PACKAGING ISSUE |
8 |
0.0008 |
| 264 |
INJURY ASSOCIATED WITH DEVICE |
17 |
0.0008 |
| 265 |
FACIAL BONES FRACTURE |
3 |
0.0008 |
| 266 |
PREMATURE RUPTURE OF MEMBRANES |
2 |
0.0008 |
| 267 |
PRODUCT USE COMPLAINT |
13 |
0.0008 |
| 268 |
FACIAL PARALYSIS |
7 |
0.0008 |
| 269 |
UTERINE LEIOMYOMA |
6 |
0.0008 |
| 270 |
URINARY INCONTINENCE |
24 |
0.0008 |
| 271 |
GAIT INABILITY |
27 |
0.0008 |
| 272 |
BLADDER DISORDER |
8 |
0.0008 |
| 273 |
PALPITATIONS |
93 |
0.0008 |
| 274 |
LOSS OF CONTROL OF LEGS |
3 |
0.0008 |
| 275 |
PURPURA |
7 |
0.0008 |
| 276 |
HOSTILITY |
2 |
0.0008 |
| 277 |
HAEMORRHAGE URINARY TRACT |
2 |
0.0008 |
| 278 |
INSURANCE ISSUE |
12 |
0.0008 |
| 279 |
ABDOMINAL INFECTION |
2 |
0.0008 |
| 280 |
HERPES SIMPLEX |
5 |
0.0008 |
| 281 |
GAIT DISTURBANCE |
147 |
0.0008 |
| 282 |
HEPATITIS TOXIC |
2 |
0.0008 |
| 283 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
2 |
0.0008 |
| 284 |
KIDNEY INFECTION |
15 |
0.0008 |
| 285 |
ATAXIA |
9 |
0.0008 |
| 286 |
THERAPY INTERRUPTED |
54 |
0.0008 |
| 287 |
GASTROINTESTINAL STROMAL TUMOUR |
2 |
0.0008 |
| 288 |
BLOOD POTASSIUM ABNORMAL |
2 |
0.0007 |
| 289 |
PRODUCT CLEANING INADEQUATE |
2 |
0.0007 |
| 290 |
GALLBLADDER OPERATION |
3 |
0.0007 |
| 291 |
INVASIVE DUCTAL BREAST CARCINOMA |
2 |
0.0007 |
| 292 |
DRUG-INDUCED LIVER INJURY |
23 |
0.0007 |
| 293 |
ANAPHYLACTOID REACTION |
3 |
0.0007 |
| 294 |
BALANCE DISORDER |
63 |
0.0007 |
| 295 |
DEVICE FAILURE |
11 |
0.0007 |
| 296 |
LIVE BIRTH |
6 |
0.0007 |
| 297 |
ELECTRIC SHOCK SENSATION |
2 |
0.0007 |
| 298 |
MUSCULAR WEAKNESS |
81 |
0.0007 |
| 299 |
PARAESTHESIA |
112 |
0.0007 |
| 300 |
MUSCLE FATIGUE |
3 |
0.0007 |
| 301 |
NECK MASS |
2 |
0.0007 |
| 302 |
INTERVERTEBRAL DISC DISORDER |
3 |
0.0007 |
| 303 |
TENSION HEADACHE |
3 |
0.0007 |
| 304 |
FIBULA FRACTURE |
2 |
0.0007 |
| 305 |
DEVICE DEFECTIVE |
12 |
0.0007 |
| 306 |
FINE MOTOR SKILL DYSFUNCTION |
2 |
0.0007 |
| 307 |
ANAPHYLACTIC REACTION |
38 |
0.0007 |
| 308 |
ABORTION |
2 |
0.0007 |
| 309 |
DYSPHEMIA |
3 |
0.0007 |
| 310 |
FEELING OF BODY TEMPERATURE CHANGE |
4 |
0.0007 |
| 311 |
NECK INJURY |
2 |
0.0007 |
| 312 |
GROWTH RETARDATION |
2 |
0.0007 |
| 313 |
MUSCLE TIGHTNESS |
11 |
0.0007 |
| 314 |
ADVERSE REACTION |
9 |
0.0007 |
| 315 |
BRADYKINESIA |
4 |
0.0007 |
| 316 |
FACIAL PAIN |
6 |
0.0007 |
| 317 |
MALIGNANT MELANOMA |
9 |
0.0007 |
| 318 |
PRODUCT DOSE OMISSION ISSUE |
197 |
0.0007 |
| 319 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 320 |
CLOSTRIDIUM DIFFICILE COLITIS |
7 |
0.0007 |
| 321 |
DYSAESTHESIA |
2 |
0.0007 |
| 322 |
RECTAL CANCER |
2 |
0.0007 |
| 323 |
ECTOPIC PREGNANCY |
2 |
0.0006 |
| 324 |
DIASTOLIC DYSFUNCTION |
2 |
0.0006 |
| 325 |
CHRONIC LYMPHOCYTIC LEUKAEMIA |
3 |
0.0006 |
| 326 |
LOSS OF CONSCIOUSNESS |
81 |
0.0006 |
| 327 |
SARCOIDOSIS |
3 |
0.0006 |
| 328 |
PRE-ECLAMPSIA |
3 |
0.0006 |
| 329 |
GESTATIONAL DIABETES |
3 |
0.0006 |
| 330 |
CYSTITIS |
20 |
0.0006 |
| 331 |
TREMOR |
103 |
0.0006 |
| 332 |
NEURALGIA |
15 |
0.0006 |
| 333 |
MICTURITION URGENCY |
7 |
0.0006 |
| 334 |
SPEECH DISORDER |
32 |
0.0006 |
| 335 |
HEPATOMEGALY |
6 |
0.0006 |
| 336 |
ASPERGILLUS INFECTION |
4 |
0.0006 |
| 337 |
HYPOGAMMAGLOBULINAEMIA |
4 |
0.0006 |
| 338 |
URTICARIA |
102 |
0.0006 |
| 339 |
WALKING AID USER |
4 |
0.0006 |
| 340 |
THERAPY CESSATION |
31 |
0.0006 |
| 341 |
HEMIPLEGIA |
5 |
0.0006 |
| 342 |
HYPOTONIA |
6 |
0.0006 |
| 343 |
COGNITIVE DISORDER |
28 |
0.0006 |
| 344 |
APHASIA |
18 |
0.0006 |
| 345 |
WRONG PRODUCT ADMINISTERED |
4 |
0.0006 |
| 346 |
BODY TEMPERATURE INCREASED |
12 |
0.0006 |
| 347 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
4 |
0.0006 |
| 348 |
EAR DISCOMFORT |
6 |
0.0006 |
| 349 |
ANKLE FRACTURE |
9 |
0.0006 |
| 350 |
ORAL PAIN |
13 |
0.0006 |
| 351 |
FUNCTIONAL GASTROINTESTINAL DISORDER |
2 |
0.0006 |
| 352 |
ENCEPHALITIS |
4 |
0.0006 |
| 353 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
117 |
0.0006 |
| 354 |
PANIC ATTACK |
21 |
0.0006 |
| 355 |
AUTOIMMUNE HEPATITIS |
4 |
0.0006 |
| 356 |
HYPERREFLEXIA |
2 |
0.0006 |
| 357 |
POST PROCEDURAL COMPLICATION |
11 |
0.0006 |
| 358 |
ERYTHEMA NODOSUM |
2 |
0.0006 |
| 359 |
MOUTH ULCERATION |
12 |
0.0006 |
| 360 |
HANGOVER |
2 |
0.0006 |
| 361 |
FACIAL PARESIS |
2 |
0.0006 |
| 362 |
PRODUCT CONTAMINATION |
2 |
0.0006 |
| 363 |
VISUAL IMPAIRMENT |
69 |
0.0006 |
| 364 |
CHEST PAIN |
103 |
0.0006 |
| 365 |
HOSPITALISATION |
85 |
0.0006 |
| 366 |
URINARY TRACT INFECTION |
94 |
0.0006 |
| 367 |
PREGNANCY |
11 |
0.0005 |
| 368 |
DYSSTASIA |
16 |
0.0005 |
| 369 |
CUTANEOUS VASCULITIS |
2 |
0.0005 |
| 370 |
JAW DISORDER |
3 |
0.0005 |
| 371 |
BRAIN NEOPLASM |
5 |
0.0005 |
| 372 |
BURNING SENSATION |
38 |
0.0005 |
| 373 |
SWELLING FACE |
35 |
0.0005 |
| 374 |
HEART RATE INCREASED |
53 |
0.0005 |
| 375 |
CHRONIC SINUSITIS |
2 |
0.0005 |
| 376 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
2 |
0.0005 |
| 377 |
PREMATURE LABOUR |
3 |
0.0005 |
| 378 |
DEVICE LEAKAGE |
23 |
0.0005 |
| 379 |
BOWEL MOVEMENT IRREGULARITY |
4 |
0.0005 |
| 380 |
MOUTH SWELLING |
3 |
0.0005 |
| 381 |
PANIC DISORDER |
2 |
0.0005 |
| 382 |
APHTHOUS ULCER |
4 |
0.0005 |
| 383 |
VASCULITIS |
6 |
0.0005 |
| 384 |
SPINAL PAIN |
6 |
0.0005 |
| 385 |
CERVIX CARCINOMA |
2 |
0.0005 |
| 386 |
COLD SWEAT |
9 |
0.0005 |
| 387 |
SYNCOPE |
51 |
0.0005 |
| 388 |
LYMPHADENOPATHY |
18 |
0.0005 |
| 389 |
COVID-19 |
89 |
0.0005 |
| 390 |
HEAD INJURY |
16 |
0.0005 |
| 391 |
INABILITY TO AFFORD MEDICATION |
5 |
0.0005 |
| 392 |
SEIZURE |
58 |
0.0005 |
| 393 |
COORDINATION ABNORMAL |
7 |
0.0005 |
| 394 |
MASS |
7 |
0.0005 |
| 395 |
UTERINE CANCER |
4 |
0.0005 |
| 396 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
13 |
0.0005 |
| 397 |
PRESYNCOPE |
12 |
0.0005 |
| 398 |
FOETAL GROWTH RESTRICTION |
3 |
0.0005 |
| 399 |
HOMICIDAL IDEATION |
2 |
0.0005 |
| 400 |
FALL |
164 |
0.0005 |
| 401 |
MOTOR DYSFUNCTION |
5 |
0.0005 |
| 402 |
DEMYELINATION |
2 |
0.0005 |
| 403 |
INFLUENZA LIKE ILLNESS |
40 |
0.0005 |
| 404 |
PARAESTHESIA ORAL |
7 |
0.0005 |
| 405 |
TEMPERATURE INTOLERANCE |
5 |
0.0005 |
| 406 |
INJECTION SITE HAEMATOMA |
7 |
0.0005 |
| 407 |
TENDERNESS |
5 |
0.0005 |
| 408 |
RENAL PAIN |
5 |
0.0005 |
| 409 |
INCORRECT DRUG ADMINISTRATION RATE |
2 |
0.0005 |
| 410 |
THERAPY NON-RESPONDER |
21 |
0.0005 |
| 411 |
MOVEMENT DISORDER |
15 |
0.0005 |
| 412 |
SKIN CANCER |
10 |
0.0005 |
| 413 |
CARDIAC FLUTTER |
3 |
0.0005 |
| 414 |
PRODUCT QUALITY ISSUE |
63 |
0.0005 |
| 415 |
MUSCLE SPASMS |
85 |
0.0005 |
| 416 |
DYSPNOEA |
261 |
0.0005 |
| 417 |
ORAL HERPES |
9 |
0.0005 |
| 418 |
SKIN SWELLING |
4 |
0.0005 |
| 419 |
MONOPLEGIA |
2 |
0.0005 |
| 420 |
REFUSAL OF TREATMENT BY PATIENT |
3 |
0.0005 |
| 421 |
MELANOCYTIC NAEVUS |
2 |
0.0005 |
| 422 |
DEVICE DIFFICULT TO USE |
30 |
0.0005 |
| 423 |
LYMPHOMA |
7 |
0.0005 |
| 424 |
HOT FLUSH |
34 |
0.0005 |
| 425 |
NERVE INJURY |
5 |
0.0004 |
| 426 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
20 |
0.0004 |
| 427 |
SKIN INFECTION |
5 |
0.0004 |
| 428 |
MENINGITIS ASEPTIC |
2 |
0.0004 |
| 429 |
OCULAR DISCOMFORT |
5 |
0.0004 |
| 430 |
ADVERSE DRUG REACTION |
40 |
0.0004 |
| 431 |
CYANOSIS |
7 |
0.0004 |
| 432 |
BACK PAIN |
103 |
0.0004 |
| 433 |
ULCER HAEMORRHAGE |
3 |
0.0004 |
| 434 |
STATUS EPILEPTICUS |
5 |
0.0004 |
| 435 |
HYPERHIDROSIS |
57 |
0.0004 |
| 436 |
PRODUCT LABEL ISSUE |
3 |
0.0004 |
| 437 |
BLINDNESS |
18 |
0.0004 |
| 438 |
PATHOGEN RESISTANCE |
4 |
0.0004 |
| 439 |
EYE MOVEMENT DISORDER |
3 |
0.0004 |
| 440 |
INJECTION SITE PAPULE |
2 |
0.0004 |
| 441 |
PERIPHERAL COLDNESS |
6 |
0.0004 |
| 442 |
SENSORY DISTURBANCE |
7 |
0.0004 |
| 443 |
RESPIRATION ABNORMAL |
3 |
0.0004 |
| 444 |
MUSCLE TWITCHING |
10 |
0.0004 |
| 445 |
CHRONIC MYELOID LEUKAEMIA |
2 |
0.0004 |
| 446 |
CAESAREAN SECTION |
5 |
0.0004 |
| 447 |
MEMORY IMPAIRMENT |
59 |
0.0004 |
| 448 |
FEELING OF DESPAIR |
2 |
0.0004 |
| 449 |
BLINDNESS UNILATERAL |
6 |
0.0004 |
| 450 |
DYSARTHRIA |
16 |
0.0004 |
| 451 |
COVID-19 PNEUMONIA |
5 |
0.0004 |
| 452 |
DIZZINESS |
210 |
0.0004 |
| 453 |
INCORRECT DOSE ADMINISTERED |
96 |
0.0004 |
| 454 |
DEVICE BREAKAGE |
17 |
0.0004 |
| 455 |
ACCIDENT |
5 |
0.0004 |
| 456 |
MACULAR DEGENERATION |
5 |
0.0004 |
| 457 |
PRURITUS GENERALISED |
9 |
0.0004 |
| 458 |
HYPERTHYROIDISM |
6 |
0.0004 |
| 459 |
NEPHROLITHIASIS |
19 |
0.0004 |
| 460 |
RASH VESICULAR |
2 |
0.0004 |
| 461 |
HYPOKINESIA |
6 |
0.0004 |
| 462 |
UNDERDOSE |
30 |
0.0004 |
| 463 |
VERTIGO |
25 |
0.0004 |
| 464 |
JAUNDICE |
11 |
0.0004 |
| 465 |
HYPERSENSITIVITY |
75 |
0.0004 |
| 466 |
CYST |
5 |
0.0004 |
| 467 |
OVARIAN CYST |
4 |
0.0004 |
| 468 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
4 |
0.0004 |
| 469 |
ERYSIPELAS |
2 |
0.0004 |
| 470 |
FEELING ABNORMAL |
95 |
0.0004 |
| 471 |
BRAIN OEDEMA |
5 |
0.0004 |
| 472 |
MUSCLE ATROPHY |
5 |
0.0004 |
| 473 |
TASTE DISORDER |
8 |
0.0004 |
| 474 |
HYPERTHERMIA |
3 |
0.0004 |
| 475 |
MUSCULOSKELETAL STIFFNESS |
34 |
0.0004 |
| 476 |
CONGENITAL ANOMALY |
3 |
0.0004 |
| 477 |
BRONCHOPULMONARY ASPERGILLOSIS |
3 |
0.0004 |
| 478 |
APNOEA |
3 |
0.0004 |
| 479 |
CONTUSION |
37 |
0.0004 |
| 480 |
ANXIETY |
109 |
0.0004 |
| 481 |
HERPES ZOSTER |
22 |
0.0004 |
| 482 |
BEDRIDDEN |
5 |
0.0004 |
| 483 |
ERYTHEMA |
78 |
0.0004 |
| 484 |
NYSTAGMUS |
2 |
0.0004 |
| 485 |
DRUG INEFFECTIVE |
496 |
0.0004 |
| 486 |
HEPATIC STEATOSIS |
7 |
0.0004 |
| 487 |
RETCHING |
8 |
0.0004 |
| 488 |
MENTAL IMPAIRMENT |
9 |
0.0004 |
| 489 |
FRUSTRATION TOLERANCE DECREASED |
3 |
0.0004 |
| 490 |
MUSCLE DISORDER |
3 |
0.0004 |
| 491 |
PAIN IN EXTREMITY |
109 |
0.0004 |
| 492 |
FOOT FRACTURE |
7 |
0.0004 |
| 493 |
POST PROCEDURAL INFECTION |
3 |
0.0004 |
| 494 |
MUSCULOSKELETAL DISORDER |
7 |
0.0004 |
| 495 |
NONSPECIFIC REACTION |
2 |
0.0004 |
| 496 |
ASTHENIA |
137 |
0.0004 |
| 497 |
CEREBRAL HAEMORRHAGE |
13 |
0.0004 |
| 498 |
DEAFNESS UNILATERAL |
2 |
0.0004 |
| 499 |
CHOKING SENSATION |
2 |
0.0004 |
| 500 |
GENERALISED TONIC-CLONIC SEIZURE |
6 |
0.0004 |
| 501 |
INJECTION SITE INJURY |
2 |
0.0004 |
| 502 |
DISCOMFORT |
22 |
0.0004 |
| 503 |
LIP SWELLING |
12 |
0.0004 |
| 504 |
ATRIAL SEPTAL DEFECT |
3 |
0.0004 |
| 505 |
WOUND |
10 |
0.0004 |
| 506 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
6 |
0.0004 |
| 507 |
CIRCULATORY COLLAPSE |
6 |
0.0004 |
| 508 |
GENERALISED ERYTHEMA |
2 |
0.0004 |
| 509 |
CARDIAC OPERATION |
3 |
0.0003 |
| 510 |
HYPERSOMNIA |
10 |
0.0003 |
| 511 |
MUSCULOSKELETAL DISCOMFORT |
6 |
0.0003 |
| 512 |
MOBILITY DECREASED |
25 |
0.0003 |
| 513 |
BLOOD MAGNESIUM DECREASED |
3 |
0.0003 |
| 514 |
HERPES VIRUS INFECTION |
2 |
0.0003 |
| 515 |
ENTEROCOLITIS |
2 |
0.0003 |
| 516 |
HYPERVENTILATION |
2 |
0.0003 |
| 517 |
NEOPLASM MALIGNANT |
23 |
0.0003 |
| 518 |
GRIP STRENGTH DECREASED |
3 |
0.0003 |
| 519 |
NECK PAIN |
19 |
0.0003 |
| 520 |
LYMPHOCYTE COUNT DECREASED |
6 |
0.0003 |
| 521 |
PLEURISY |
2 |
0.0003 |
| 522 |
KNEE ARTHROPLASTY |
7 |
0.0003 |
| 523 |
THYROID CANCER |
4 |
0.0003 |
| 524 |
FOETAL EXPOSURE DURING PREGNANCY |
27 |
0.0003 |
| 525 |
SWELLING |
31 |
0.0003 |
| 526 |
INGUINAL HERNIA |
2 |
0.0003 |
| 527 |
SKIN DISCOLOURATION |
15 |
0.0003 |
| 528 |
SPINAL OPERATION |
4 |
0.0003 |
| 529 |
CONCOMITANT DISEASE AGGRAVATED |
2 |
0.0003 |
| 530 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
7 |
0.0003 |
| 531 |
THINKING ABNORMAL |
6 |
0.0003 |
| 532 |
DEPRESSED MOOD |
17 |
0.0003 |
| 533 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 534 |
DISEASE PROGRESSION |
38 |
0.0003 |
| 535 |
FLANK PAIN |
3 |
0.0003 |
| 536 |
BRAIN FOG |
5 |
0.0003 |
| 537 |
PRODUCT DOSE OMISSION IN ERROR |
9 |
0.0003 |
| 538 |
PREMATURE DELIVERY |
5 |
0.0003 |
| 539 |
INCREASED APPETITE |
6 |
0.0003 |
| 540 |
VISION BLURRED |
43 |
0.0003 |
| 541 |
ILLNESS |
32 |
0.0003 |
| 542 |
AUTOIMMUNE DISORDER |
3 |
0.0003 |
| 543 |
PARKINSONISM |
3 |
0.0003 |
| 544 |
INFLAMMATORY BOWEL DISEASE |
3 |
0.0003 |
| 545 |
DECREASED IMMUNE RESPONSIVENESS |
3 |
0.0003 |
| 546 |
DISABILITY |
6 |
0.0003 |
| 547 |
LIGAMENT SPRAIN |
3 |
0.0003 |
| 548 |
SARS-COV-2 TEST POSITIVE |
4 |
0.0003 |
| 549 |
SKIN MASS |
2 |
0.0003 |
| 550 |
POST-TRAUMATIC STRESS DISORDER |
2 |
0.0003 |
| 551 |
PRODUCT ADMINISTRATION ERROR |
6 |
0.0003 |
| 552 |
EPILEPSY |
9 |
0.0003 |
| 553 |
FATIGUE |
229 |
0.0003 |
| 554 |
DRUG EXPOSURE DURING PREGNANCY |
10 |
0.0003 |
| 555 |
TREATMENT NONCOMPLIANCE |
16 |
0.0003 |
| 556 |
PARANOIA |
5 |
0.0003 |
| 557 |
LYMPHOEDEMA |
2 |
0.0003 |
| 558 |
DIVERTICULITIS |
8 |
0.0003 |
| 559 |
FIBROMYALGIA |
7 |
0.0003 |
| 560 |
ORTHOSTATIC HYPOTENSION |
5 |
0.0003 |
| 561 |
WEIGHT FLUCTUATION |
3 |
0.0003 |
| 562 |
EXTRASYSTOLES |
2 |
0.0003 |
| 563 |
DEFAECATION URGENCY |
2 |
0.0003 |
| 564 |
ENCEPHALOPATHY |
7 |
0.0003 |
| 565 |
CONFUSIONAL STATE |
46 |
0.0003 |
| 566 |
HALLUCINATION, VISUAL |
6 |
0.0003 |
| 567 |
SKIN IRRITATION |
13 |
0.0003 |
| 568 |
HAND FRACTURE |
2 |
0.0003 |
| 569 |
HEADACHE |
176 |
0.0003 |
| 570 |
LEUKOPENIA |
14 |
0.0003 |
| 571 |
LETHARGY |
16 |
0.0003 |
| 572 |
PANIC REACTION |
2 |
0.0003 |
| 573 |
LEUKOCYTOSIS |
5 |
0.0003 |
| 574 |
BIPOLAR DISORDER |
3 |
0.0003 |
| 575 |
PRODUCT DISPENSING ERROR |
6 |
0.0003 |
| 576 |
STAPHYLOCOCCAL INFECTION |
9 |
0.0003 |
| 577 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
5 |
0.0003 |
| 578 |
MIGRAINE |
26 |
0.0003 |
| 579 |
PAIN |
167 |
0.0003 |
| 580 |
PYREXIA |
94 |
0.0003 |
| 581 |
SENSITIVE SKIN |
2 |
0.0003 |
| 582 |
PSYCHIATRIC SYMPTOM |
2 |
0.0003 |
| 583 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
13 |
0.0003 |
| 584 |
DEVICE MALFUNCTION |
19 |
0.0003 |
| 585 |
CEREBRAL DISORDER |
2 |
0.0003 |
| 586 |
DRUG EFFECT LESS THAN EXPECTED |
4 |
0.0003 |
| 587 |
FEELING DRUNK |
2 |
0.0003 |
| 588 |
EYE SWELLING |
10 |
0.0003 |
| 589 |
RESPIRATORY TRACT INFECTION |
7 |
0.0003 |
| 590 |
DEPRESSION |
61 |
0.0003 |
| 591 |
HEPATIC FUNCTION ABNORMAL |
10 |
0.0003 |
| 592 |
EYE INFECTION |
3 |
0.0003 |
| 593 |
INTESTINAL OBSTRUCTION |
10 |
0.0003 |
| 594 |
MITRAL VALVE INCOMPETENCE |
3 |
0.0003 |
| 595 |
PEMPHIGOID |
2 |
0.0003 |
| 596 |
PRODUCT AVAILABILITY ISSUE |
6 |
0.0003 |
| 597 |
ABDOMINAL DISCOMFORT |
44 |
0.0003 |
| 598 |
TINNITUS |
12 |
0.0003 |
| 599 |
DEVICE PHYSICAL PROPERTY ISSUE |
2 |
0.0003 |
| 600 |
NEOPLASM |
3 |
0.0003 |
| 601 |
LOWER LIMB FRACTURE |
5 |
0.0003 |
| 602 |
CONDITION AGGRAVATED |
79 |
0.0003 |
| 603 |
UPPER RESPIRATORY TRACT INFECTION |
12 |
0.0003 |
| 604 |
ATRIOVENTRICULAR BLOCK |
2 |
0.0003 |
| 605 |
CELLULITIS |
13 |
0.0003 |
| 606 |
LIMB INJURY |
7 |
0.0003 |
| 607 |
EAR PAIN |
5 |
0.0003 |
| 608 |
GASTROINTESTINAL DISORDER |
23 |
0.0003 |
| 609 |
BASAL CELL CARCINOMA |
4 |
0.0003 |
| 610 |
CHOKING |
5 |
0.0003 |
| 611 |
SWOLLEN TONGUE |
8 |
0.0003 |
| 612 |
DEVICE DELIVERY SYSTEM ISSUE |
7 |
0.0003 |
| 613 |
SKIN LESION |
7 |
0.0003 |
| 614 |
RESPIRATORY ARREST |
7 |
0.0003 |
| 615 |
SINUS DISORDER |
5 |
0.0003 |
| 616 |
PNEUMOTHORAX |
4 |
0.0003 |
| 617 |
LOW BIRTH WEIGHT BABY |
2 |
0.0003 |
| 618 |
ULCER |
4 |
0.0003 |
| 619 |
INFLUENZA |
28 |
0.0003 |
| 620 |
ABSCESS |
4 |
0.0003 |
| 621 |
WRIST FRACTURE |
3 |
0.0003 |
| 622 |
WEIGHT INCREASED |
56 |
0.0002 |
| 623 |
ANGIOEDEMA |
11 |
0.0002 |
| 624 |
RHINITIS |
2 |
0.0002 |
| 625 |
NAUSEA |
195 |
0.0002 |
| 626 |
COLITIS ULCERATIVE |
11 |
0.0002 |
| 627 |
DYSKINESIA |
10 |
0.0002 |
| 628 |
AMNESIA |
16 |
0.0002 |
| 629 |
DECUBITUS ULCER |
2 |
0.0002 |
| 630 |
EYE DISORDER |
8 |
0.0002 |
| 631 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
0.0002 |
| 632 |
FUNGAL INFECTION |
8 |
0.0002 |
| 633 |
EOSINOPHIL COUNT INCREASED |
2 |
0.0002 |
| 634 |
DYSPHONIA |
14 |
0.0002 |
| 635 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
17 |
0.0002 |
| 636 |
COLITIS |
9 |
0.0002 |
| 637 |
FACE OEDEMA |
4 |
0.0002 |
| 638 |
INFECTION |
34 |
0.0002 |
| 639 |
JOINT INJURY |
5 |
0.0002 |
| 640 |
ROTATOR CUFF SYNDROME |
3 |
0.0002 |
| 641 |
DRUG RESISTANCE |
6 |
0.0002 |
| 642 |
NASOPHARYNGITIS |
43 |
0.0002 |
| 643 |
RASH GENERALISED |
6 |
0.0002 |
| 644 |
NEUROPATHY PERIPHERAL |
22 |
0.0002 |
| 645 |
MUSCLE STRAIN |
2 |
0.0002 |
| 646 |
ALTERED STATE OF CONSCIOUSNESS |
5 |
0.0002 |
| 647 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 648 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 649 |
PRODUCT STORAGE ERROR |
20 |
0.0002 |
| 650 |
ORAL CANDIDIASIS |
3 |
0.0002 |
| 651 |
IMMUNE SYSTEM DISORDER |
3 |
0.0002 |
| 652 |
TOOTH INFECTION |
3 |
0.0002 |
| 653 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
41 |
0.0002 |
| 654 |
DYSMENORRHOEA |
3 |
0.0002 |
| 655 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 656 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
5 |
0.0002 |
| 657 |
GASTROENTERITIS VIRAL |
4 |
0.0002 |
| 658 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 659 |
LIP DRY |
2 |
0.0002 |
| 660 |
RESTLESS LEGS SYNDROME |
4 |
0.0002 |
| 661 |
RETINAL DETACHMENT |
2 |
0.0002 |
| 662 |
OVARIAN CANCER |
2 |
0.0002 |
| 663 |
MALAISE |
95 |
0.0002 |
| 664 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 665 |
POLLAKIURIA |
9 |
0.0002 |
| 666 |
APHONIA |
3 |
0.0002 |
| 667 |
DEMENTIA |
6 |
0.0002 |
| 668 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 669 |
CARPAL TUNNEL SYNDROME |
3 |
0.0002 |
| 670 |
APPENDICITIS |
2 |
0.0002 |
| 671 |
DIARRHOEA HAEMORRHAGIC |
2 |
0.0002 |
| 672 |
LEUKAEMIA |
2 |
0.0002 |
| 673 |
PAIN IN JAW |
6 |
0.0002 |
| 674 |
THROMBOSIS |
17 |
0.0002 |
| 675 |
VOMITING |
99 |
0.0002 |
| 676 |
PROTEINURIA |
4 |
0.0002 |
| 677 |
VIRAL INFECTION |
7 |
0.0002 |
| 678 |
URINARY RETENTION |
7 |
0.0002 |
| 679 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
2 |
0.0002 |
| 680 |
EXPOSURE DURING PREGNANCY |
13 |
0.0002 |
| 681 |
IMPAIRED QUALITY OF LIFE |
3 |
0.0002 |
| 682 |
PULMONARY FIBROSIS |
4 |
0.0002 |
| 683 |
PRURITUS |
80 |
0.0002 |
| 684 |
AFFECT LABILITY |
2 |
0.0002 |
| 685 |
MYELODYSPLASTIC SYNDROME |
3 |
0.0002 |
| 686 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
7 |
0.0002 |
| 687 |
SURGERY |
12 |
0.0002 |
| 688 |
ASCITES |
6 |
0.0002 |
| 689 |
COELIAC DISEASE |
2 |
0.0002 |
| 690 |
MENORRHAGIA |
4 |
0.0002 |
| 691 |
HOSPICE CARE |
2 |
0.0002 |
| 692 |
DYSGEUSIA |
15 |
0.0002 |
| 693 |
THROAT IRRITATION |
9 |
0.0002 |
| 694 |
RASH MACULAR |
7 |
0.0002 |
| 695 |
BRAIN INJURY |
2 |
0.0002 |
| 696 |
HEART RATE DECREASED |
7 |
0.0002 |
| 697 |
HEPATIC FAILURE |
6 |
0.0002 |
| 698 |
GENERAL PHYSICAL HEALTH DETERIORATION |
23 |
0.0002 |
| 699 |
SOMNOLENCE |
40 |
0.0002 |
| 700 |
BLOOD PRESSURE INCREASED |
30 |
0.0002 |
| 701 |
HIP ARTHROPLASTY |
3 |
0.0002 |
| 702 |
DELUSION |
3 |
0.0002 |
| 703 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
9 |
0.0002 |
| 704 |
NERVOUS SYSTEM DISORDER |
6 |
0.0002 |
| 705 |
NERVOUSNESS |
10 |
0.0002 |
| 706 |
WEIGHT DECREASED |
53 |
0.0002 |
| 707 |
SCRATCH |
2 |
0.0002 |
| 708 |
MOOD SWINGS |
6 |
0.0002 |
| 709 |
MYALGIA |
32 |
0.0002 |
| 710 |
SCIATICA |
3 |
0.0002 |
| 711 |
EAR INFECTION |
5 |
0.0002 |
| 712 |
EATING DISORDER |
4 |
0.0002 |
| 713 |
HIP FRACTURE |
6 |
0.0002 |
| 714 |
BREAST CANCER METASTATIC |
2 |
0.0002 |
| 715 |
FEAR |
5 |
0.0002 |
| 716 |
SUICIDAL IDEATION |
17 |
0.0002 |
| 717 |
DECREASED ACTIVITY |
2 |
0.0002 |
| 718 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 719 |
MENSTRUATION DELAYED |
2 |
0.0002 |
| 720 |
BACK DISORDER |
3 |
0.0002 |
| 721 |
BACK INJURY |
2 |
0.0002 |
| 722 |
PALLOR |
5 |
0.0002 |
| 723 |
IMPAIRED HEALING |
6 |
0.0002 |
| 724 |
GASTROINTESTINAL PAIN |
2 |
0.0002 |
| 725 |
VISUAL ACUITY REDUCED |
6 |
0.0002 |
| 726 |
FOOT DEFORMITY |
2 |
0.0002 |
| 727 |
ABDOMINAL PAIN UPPER |
37 |
0.0002 |
| 728 |
DYSPHAGIA |
17 |
0.0002 |
| 729 |
OXYGEN SATURATION DECREASED |
10 |
0.0002 |
| 730 |
EYE PAIN |
10 |
0.0002 |
| 731 |
CHROMATURIA |
4 |
0.0002 |
| 732 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 733 |
DRUG INTOLERANCE |
17 |
0.0002 |
| 734 |
LOWER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 735 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 736 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 737 |
SCAB |
2 |
0.0002 |
| 738 |
ACCIDENTAL EXPOSURE TO PRODUCT |
18 |
0.0002 |
| 739 |
SHOCK |
4 |
0.0002 |
| 740 |
AMENORRHOEA |
3 |
0.0002 |
| 741 |
METASTASES TO LIVER |
3 |
0.0002 |
| 742 |
DISEASE RECURRENCE |
8 |
0.0002 |
| 743 |
PRODUCT PRESCRIBING ERROR |
4 |
0.0002 |
| 744 |
THIRST |
3 |
0.0002 |
| 745 |
ROAD TRAFFIC ACCIDENT |
7 |
0.0002 |
| 746 |
RASH PRURITIC |
9 |
0.0002 |
| 747 |
HEPATITIS C |
2 |
0.0002 |
| 748 |
LOCALISED INFECTION |
4 |
0.0002 |
| 749 |
PELVIC PAIN |
3 |
0.0002 |
| 750 |
NOCTURIA |
2 |
0.0002 |
| 751 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 752 |
SEPSIS |
18 |
0.0002 |
| 753 |
BREAST CANCER |
15 |
0.0002 |
| 754 |
ILEUS |
2 |
0.0002 |
| 755 |
PHOTOPHOBIA |
3 |
0.0002 |
| 756 |
CEREBROVASCULAR ACCIDENT |
27 |
0.0002 |
| 757 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 758 |
RASH |
69 |
0.0002 |
| 759 |
BLOOD URINE PRESENT |
3 |
0.0002 |
| 760 |
ALOPECIA |
31 |
0.0002 |
| 761 |
INSOMNIA |
42 |
0.0002 |
| 762 |
TACHYCARDIA |
14 |
0.0002 |
| 763 |
THERAPEUTIC RESPONSE UNEXPECTED |
7 |
0.0002 |
| 764 |
SLEEP DISORDER |
11 |
0.0002 |
| 765 |
HYPERTENSION |
33 |
0.0002 |
| 766 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 767 |
INFLAMMATION |
8 |
0.0002 |
| 768 |
PNEUMONIA |
50 |
0.0002 |
| 769 |
DEAFNESS |
4 |
0.0002 |
| 770 |
PULMONARY CONGESTION |
2 |
0.0002 |
| 771 |
BLOOD PRESSURE ABNORMAL |
3 |
0.0002 |
| 772 |
ABDOMINAL PAIN |
35 |
0.0002 |
| 773 |
DEHYDRATION |
20 |
0.0001 |
| 774 |
SKIN DISORDER |
5 |
0.0001 |
| 775 |
EYE HAEMORRHAGE |
2 |
0.0001 |
| 776 |
COUGH |
42 |
0.0001 |
| 777 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 778 |
ANGER |
5 |
0.0001 |
| 779 |
PRODUCT TASTE ABNORMAL |
2 |
0.0001 |
| 780 |
SINUSITIS |
15 |
0.0001 |
| 781 |
ACUTE HEPATIC FAILURE |
2 |
0.0001 |
| 782 |
RIB FRACTURE |
3 |
0.0001 |
| 783 |
GASTRIC DISORDER |
5 |
0.0001 |
| 784 |
ARTHRALGIA |
60 |
0.0001 |
| 785 |
ABDOMINAL DISTENSION |
15 |
0.0001 |
| 786 |
LUNG DISORDER |
7 |
0.0001 |
| 787 |
PERIPHERAL SWELLING |
22 |
0.0001 |
| 788 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 789 |
ADVERSE EVENT |
13 |
0.0001 |
| 790 |
OROPHARYNGEAL PAIN |
13 |
0.0001 |
| 791 |
CARDIOGENIC SHOCK |
2 |
0.0001 |
| 792 |
HYPOACUSIS |
6 |
0.0001 |
| 793 |
DRUG INTERACTION |
22 |
0.0001 |
| 794 |
FAECES DISCOLOURED |
3 |
0.0001 |
| 795 |
GASTROENTERITIS |
2 |
0.0001 |
| 796 |
PULMONARY EMBOLISM |
13 |
0.0001 |
| 797 |
DYSURIA |
5 |
0.0001 |
| 798 |
PSYCHOTIC DISORDER |
4 |
0.0001 |
| 799 |
TOOTH DISORDER |
3 |
0.0001 |
| 800 |
HEPATOTOXICITY |
3 |
0.0001 |
| 801 |
PULMONARY MASS |
2 |
0.0001 |
| 802 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 803 |
GLOSSODYNIA |
3 |
0.0001 |
| 804 |
MUSCULOSKELETAL PAIN |
7 |
0.0001 |
| 805 |
PREMATURE BABY |
4 |
0.0001 |
| 806 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 807 |
OSTEOPENIA |
2 |
0.0001 |
| 808 |
ILL-DEFINED DISORDER |
8 |
0.0001 |
| 809 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 810 |
RENAL DISORDER |
6 |
0.0001 |
| 811 |
MENINGIOMA |
2 |
0.0001 |
| 812 |
DISORIENTATION |
5 |
0.0001 |
| 813 |
MYOCARDIAL INFARCTION |
22 |
0.0001 |
| 814 |
ARTHROPATHY |
7 |
0.0001 |
| 815 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 816 |
HYPOTHYROIDISM |
4 |
0.0001 |
| 817 |
HYPONATRAEMIA |
7 |
0.0001 |
| 818 |
NIGHT SWEATS |
4 |
0.0001 |
| 819 |
DRY MOUTH |
10 |
0.0001 |
| 820 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 821 |
PRODUCT USE ISSUE |
23 |
0.0001 |
| 822 |
CHOLELITHIASIS |
4 |
0.0001 |
| 823 |
METASTASES TO BONE |
2 |
0.0001 |
| 824 |
OSTEONECROSIS |
4 |
0.0001 |
| 825 |
MANIA |
2 |
0.0001 |
| 826 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 827 |
ABDOMINAL PAIN LOWER |
3 |
0.0001 |
| 828 |
CANDIDA INFECTION |
2 |
0.0001 |
| 829 |
HAEMATEMESIS |
3 |
0.0001 |
| 830 |
DIABETES MELLITUS |
9 |
0.0001 |
| 831 |
OSTEOARTHRITIS |
5 |
0.0001 |
| 832 |
HEPATITIS |
3 |
0.0001 |
| 833 |
UNRESPONSIVE TO STIMULI |
3 |
0.0001 |
| 834 |
SKIN ULCER |
3 |
0.0001 |
| 835 |
HAEMATOMA |
3 |
0.0001 |
| 836 |
DEVICE USE ERROR |
4 |
0.0001 |
| 837 |
PLEURAL EFFUSION |
7 |
0.0001 |
| 838 |
DRUG DOSE OMISSION |
19 |
0.0001 |
| 839 |
DRUG DOSE OMISSION BY DEVICE |
9 |
0.0001 |
| 840 |
SEDATION |
3 |
0.0001 |
| 841 |
ARTHRITIS |
9 |
0.0001 |
| 842 |
ANHEDONIA |
3 |
0.0001 |
| 843 |
INTENTIONAL PRODUCT USE ISSUE |
10 |
0.0001 |
| 844 |
GASTRITIS |
3 |
0.0001 |
| 845 |
ASPARTATE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 846 |
MENSTRUATION IRREGULAR |
3 |
0.0001 |
| 847 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
4 |
0.0001 |
| 848 |
OSTEOMYELITIS |
2 |
0.0001 |
| 849 |
CONSTIPATION |
24 |
0.0001 |
| 850 |
BONE DISORDER |
2 |
0.0001 |
| 851 |
HAEMATOCHEZIA |
6 |
0.0001 |
| 852 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 853 |
OFF LABEL USE |
95 |
0.0001 |
| 854 |
DIARRHOEA |
70 |
0.0001 |
| 855 |
MENTAL STATUS CHANGES |
3 |
0.0001 |
| 856 |
MEDICATION ERROR |
6 |
0.0001 |
| 857 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 858 |
EPISTAXIS |
8 |
0.0001 |
| 859 |
CARDIAC DISORDER |
10 |
0.0001 |
| 860 |
OEDEMA PERIPHERAL |
13 |
0.0001 |
| 861 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 862 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 863 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 864 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 865 |
GASTRIC ULCER |
2 |
0.0001 |
| 866 |
RASH ERYTHEMATOUS |
5 |
0.0001 |
| 867 |
CHOLESTASIS |
2 |
0.0001 |
| 868 |
GLAUCOMA |
2 |
0.0001 |
| 869 |
HERNIA |
2 |
0.0001 |
| 870 |
ERUCTATION |
2 |
0.0001 |
| 871 |
DECREASED APPETITE |
24 |
0.0001 |
| 872 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 873 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
3 |
0.0001 |
| 874 |
BLOOD POTASSIUM DECREASED |
3 |
0.0001 |
| 875 |
INJURY |
7 |
0.0001 |
| 876 |
NO ADVERSE EVENT |
18 |
0.0001 |
| 877 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 878 |
RENAL FAILURE |
13 |
0.0001 |
| 879 |
SKIN EXFOLIATION |
8 |
0.0001 |
| 880 |
BRONCHITIS |
7 |
0.0001 |
| 881 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 882 |
HALLUCINATION |
7 |
0.0001 |
| 883 |
VAGINAL HAEMORRHAGE |
4 |
0.0001 |
| 884 |
INTERVERTEBRAL DISC PROTRUSION |
2 |
0.0001 |
| 885 |
APPLICATION SITE PAIN |
2 |
0.0001 |
| 886 |
BLOOD PRESSURE DECREASED |
6 |
0.0001 |
| 887 |
LIVER DISORDER |
4 |
0.0001 |
| 888 |
RASH PAPULAR |
2 |
0.0001 |
| 889 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 890 |
NEUTROPENIA |
12 |
0.0001 |
| 891 |
HAEMATURIA |
3 |
0.0001 |
| 892 |
HYPOKALAEMIA |
4 |
0.0001 |
| 893 |
HAEMORRHAGE |
9 |
0.0001 |
| 894 |
DEATH |
73 |
0.0001 |
| 895 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
3 |
0.0001 |
| 896 |
WHEEZING |
5 |
0.0001 |
| 897 |
BLOOD PRESSURE FLUCTUATION |
2 |
0.0001 |
| 898 |
IRRITABILITY |
5 |
0.0001 |
| 899 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
3 |
0.0001 |
| 900 |
CRYING |
3 |
0.0001 |
| 901 |
THERAPEUTIC RESPONSE DECREASED |
5 |
0.0001 |
| 902 |
RESPIRATORY FAILURE |
6 |
0.0001 |
| 903 |
ALANINE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 904 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
2 |
0.0001 |
| 905 |
CARDIOVASCULAR DISORDER |
2 |
0.0001 |
| 906 |
WHITE BLOOD CELL COUNT INCREASED |
3 |
0.0001 |
| 907 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 908 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 909 |
PANCREATITIS |
4 |
0.0001 |
| 910 |
BRADYCARDIA |
4 |
0.0001 |
| 911 |
CARDIAC FAILURE |
6 |
0.0001 |
| 912 |
CARDIAC FAILURE CONGESTIVE |
6 |
0.0001 |
| 913 |
PAIN OF SKIN |
2 |
0.0001 |
| 914 |
DRUG EFFECT DECREASED |
4 |
0.0001 |
| 915 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 916 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 917 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
| 918 |
MOOD ALTERED |
2 |
0.0001 |
| 919 |
PRODUCT USE IN UNAPPROVED INDICATION |
18 |
0.0001 |
| 920 |
TREATMENT FAILURE |
6 |
0.0001 |
| 921 |
BLISTER |
4 |
0.0001 |
| 922 |
DYSPEPSIA |
7 |
0.0001 |
| 923 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 924 |
CONVULSION |
4 |
0.0001 |
| 925 |
SEPTIC SHOCK |
3 |
0.0001 |
| 926 |
MENTAL DISORDER |
3 |
0.0001 |
| 927 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 928 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 929 |
PULMONARY OEDEMA |
3 |
0.0001 |
| 930 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 931 |
LACRIMATION INCREASED |
2 |
0.0001 |
| 932 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 933 |
FEMUR FRACTURE |
2 |
0.0001 |
| 934 |
ARRHYTHMIA |
3 |
0.0001 |
| 935 |
COMA |
3 |
0.0001 |
| 936 |
RENAL CANCER |
3 |
0.0001 |
| 937 |
ASTHMA |
7 |
0.0001 |
| 938 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 939 |
DRY EYE |
3 |
0.0001 |
| 940 |
AGGRESSION |
3 |
0.0001 |
| 941 |
GASTROINTESTINAL HAEMORRHAGE |
5 |
0.0001 |
| 942 |
HYPOTENSION |
12 |
0.0001 |
| 943 |
EYE PRURITUS |
2 |
0.0001 |
| 944 |
FLUID RETENTION |
3 |
0.0001 |
| 945 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
3 |
0.0001 |
| 946 |
ECZEMA |
3 |
0.0001 |
| 947 |
HYPOXIA |
2 |
0.0001 |
| 948 |
PRODUCT ADHESION ISSUE |
2 |
0.0001 |
| 949 |
SKIN BURNING SENSATION |
4 |
0.0001 |
| 950 |
DISTURBANCE IN ATTENTION |
3 |
0.0001 |
| 951 |
WHITE BLOOD CELL COUNT DECREASED |
6 |
0.0001 |
| 952 |
OEDEMA |
3 |
0.0001 |
| 953 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 954 |
RESTLESSNESS |
2 |
0.0001 |
| 955 |
UNEVALUABLE EVENT |
4 |
0.0001 |
| 956 |
DRY SKIN |
7 |
0.0001 |
| 957 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 958 |
BONE PAIN |
3 |
0.0001 |
| 959 |
NASAL CONGESTION |
3 |
0.0001 |
| 960 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 961 |
CATARACT |
3 |
0.0001 |
| 962 |
JOINT SWELLING |
6 |
0.0000 |
| 963 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 964 |
OSTEOPOROSIS |
2 |
0.0000 |
| 965 |
CARDIAC ARREST |
4 |
0.0000 |
| 966 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 967 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 968 |
RENAL FAILURE ACUTE |
2 |
0.0000 |
| 969 |
RHINORRHOEA |
3 |
0.0000 |
| 970 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 971 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 972 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 973 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 974 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 975 |
AGITATION |
3 |
0.0000 |
| 976 |
CHRONIC KIDNEY DISEASE |
3 |
0.0000 |
| 977 |
PSORIASIS |
5 |
0.0000 |
| 978 |
PROSTATE CANCER |
3 |
0.0000 |
| 979 |
GASTROOESOPHAGEAL REFLUX DISEASE |
3 |
0.0000 |
| 980 |
ANAEMIA |
7 |
0.0000 |
| 981 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 982 |
COMPLETED SUICIDE |
3 |
0.0000 |
| 983 |
PANCYTOPENIA |
2 |
0.0000 |
| 984 |
FLATULENCE |
2 |
0.0000 |
| 985 |
EYE IRRITATION |
2 |
0.0000 |
| 986 |
BLADDER CANCER |
2 |
0.0000 |
| 987 |
EMOTIONAL DISTRESS |
4 |
0.0000 |
| 988 |
DRUG ABUSE |
2 |
0.0000 |
| 989 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 990 |
OVERDOSE |
4 |
0.0000 |
| 991 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 992 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |